6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 21 Sep 2022
- Reporting date
- 21 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,798 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 926-950 of 1,000 matching filings.
Per page
25
Current page
38
4
File 001-36033
4 filing
- Filing date
- 20 Sep 2022
- Reporting date
- 16 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D/A
AMENDMENT TO FORM SC 13D
- Filing date
- 20 Sep 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
25-NSE
File 001-15170
25-NSE filing
- Filing date
- 15 Sep 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Sep 2022
- Reporting date
- 13 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Sep 2022
- Reporting date
- 08 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK PROVIDES UPDATE ON FDA REVIEW OF DAPRODUSTAT
- Filing date
- 06 Sep 2022
- Reporting date
- 06 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
25-NSE
File 001-15170
25-NSE filing
- Filing date
- 01 Sep 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Sep 2022
- Reporting date
- 01 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK BOARD CHANGES
- Filing date
- 24 Aug 2022
- Reporting date
- 24 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 22 Aug 2022
- Reporting date
- 22 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
FDA NEW DRUG APPLICATION FILE ACCEPTANCE FOR MMB
- Filing date
- 17 Aug 2022
- Reporting date
- 17 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
STATEMENT: ZANTAC (RANITIDINE) LITIGATION UPDATE
- Filing date
- 17 Aug 2022
- Reporting date
- 17 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK COMPLETES ACQUISITION OF AFFINIVAX, INC.
- Filing date
- 16 Aug 2022
- Reporting date
- 16 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
STATEMENT: ZANTAC (RANITIDINE) LITIGATION
- Filing date
- 12 Aug 2022
- Reporting date
- 12 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 11 Aug 2022
- Reporting date
- 11 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 10 Aug 2022
- Reporting date
- 10 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
CURRENT REPORT OF FOREIGN ISSUER
- Filing date
- 03 Aug 2022
- Reporting date
- 03 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D/A
AMENDMENT TO FORM SC 13D
- Filing date
- 03 Aug 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Aug 2022
- Reporting date
- 01 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 01 Aug 2022
- Reporting date
- 01 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 29 Jul 2022
- Reporting date
- 29 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK BOARD CHANGE
- Filing date
- 29 Jul 2022
- Reporting date
- 29 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 28 Jul 2022
- Reporting date
- 28 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D
SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
- Filing date
- 27 Jul 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing